Risk of Thrombosis Over 2-Fold Higher in Male Breast Cancer With Tamoxifen (CME/CE)
(MedPage Today) -- Increased rate for men consistent with that found in women -- maybe higher (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 12, 2019 Category: Cardiology Source Type: news
Thrombosis a Risk With Tamoxifen in Male Breast Cancer
(MedPage Today) -- Data consistent with findings in women (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 6, 2019 Category: Cardiology Source Type: news
USPSTF: Offer Breast Ca Meds to Women at Higher Risk
(MedPage Today) -- But task force says " no " to tamoxifen, raloxifene, or AIs for women at lower risk (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 16, 2019 Category: Hematology Source Type: news
New Tool Calculates Breast Cancer Risk With Greater Precision
(CNN) — UK scientists have developed an online calculator that could enable doctors to more accurately predict a patient’s chance of developing breast cancer.
If rolled out, the new tool could change the way in which the condition is treated.
Among other things, details of family history, genetics, weight, alcohol consumption, age at menopause and use of hormone replacement therapy will all be considered by doctors when assessing a woman’s risk of developing breast cancer — the most common form of cancer in the UK.
Each of these factors has “a small impact on the likelihood of developing the d...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 15, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Breast Cancer CNN Local TV Source Type: news
Clear rub-on gel could cut the risk of breast cancer by starving cells of oestrogen
The clear and odourless gel contains a form of the anti-cancer drug tamoxifen, which has been used for years to treat women with the disease by reducing levels of the hormone oestrogen. (Source: the Mail online | Health)
Source: the Mail online | Health - January 8, 2019 Category: Consumer Health News Source Type: news
Breaking down AGEs: Insight into how lifestyle drives ER-positive breast cancer
(Medical University of South Carolina) Consumption of processed foods high in sugar and fat increase levels of advanced glycation end products (AGEs). Medical University of South Carolina researchers report that AGE levels are higher in patients with estrogen receptor (ER)-positive than ER-negative breast cancer. Addition of AGEs caused breast cancer cells, whose growth had previously been controlled by tamoxifen, to begin to grow again. This suggests that patients with high AGEs may be less likely to respond to tamoxifen treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 27, 2018 Category: Cancer & Oncology Source Type: news
Medication Beliefs Affect Uptake of Preventive Tx for Breast Cancer
Uptake of preventive therapy low among those with strong concerns about tamoxifen, meds in general (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 14, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Journal, Source Type: news
Medication Beliefs Affect Uptake of Preventive Therapy for Breast Cancer
FRIDAY, Dec. 14, 2018 -- Beliefs about medication are associated with uptake of tamoxifen as a preventive therapy among women at increased risk for breast cancer, according to a study published online Dec. 2 in Clinical Breast Cancer.
Rachael Jane... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 14, 2018 Category: Pharmaceuticals Source Type: news
Medication Beliefs Affect Uptake of Preventive Tx for Breast Cancer
FRIDAY, Dec. 14, 2018 -- Beliefs about medication are associated with uptake of tamoxifen as a preventive therapy among women at increased risk for breast cancer, according to a study published online Dec. 2 in Clinical Breast Cancer.
Rachael Jane... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 14, 2018 Category: Pharmaceuticals Source Type: news
Are male doctors too complacent about the cancer pill many women say is ruining their lives?
Tamoxifen is a daily pill taken by about 550,000 British breast cancer survivors. It can slash their risk of recurrence after treatment by up to 45 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2018 Category: Consumer Health News Source Type: news
Are male doctors too complacent about the cancer pill many women say is ruining their lives?
Tamoxifen is a daily pill taken by about 550,000 British breast cancer survivors. It can slash their risk of recurrence after treatment by up to 45 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2018 Category: Consumer Health News Source Type: news
Go Low With Tamoxifen for DCIS Go Low With Tamoxifen for DCIS
In a potentially practice-changing result, use of a 5-mg daily dose of tamoxifen for patients with ductal carcinoma in situ (DCIS) prevented new and recurrent breast cancer events in comparison with placebo.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 7, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Tamoxifen at a Lower Dose Might Still Prevent Breast Cancer's Return
Title: Tamoxifen at a Lower Dose Might Still Prevent Breast Cancer's ReturnCategory: Health NewsCreated: 12/6/2018 12:00:00 AMLast Editorial Review: 12/7/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 7, 2018 Category: Cancer & Oncology Source Type: news
Low-Dose Tamoxifen Feasible Option in Breast Cancer
(MedPage Today) -- Women appear to prevent recurrence in early stage cancers with 5 mg dosing (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - December 6, 2018 Category: Surgery Source Type: news
Can Low-Dose Tamoxifen Prevent Recurrences With Reduced Toxicity?
The TAM01 trial looked at whether a 5-mg/day dose of tamoxifen was effective in patients with breast intraepithelial neoplasia, or if the 20-mg/day dose was still the best option. (Source: CancerNetwork)
Source: CancerNetwork - December 6, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news
